Lilly partners with Nvidia on AI supercomputer to speed up drug development
Update: 2025-10-29
Description
Eli Lilly partners with Nvidia to build a supercomputer, leveraging AI for faster and more efficient drug discovery. The new system will allow scientists to explore a wider range of potential new drugs, with some AI models available on a secure platform called TuneLab. This move marks a shift in Lilly's approach to AI, seeing it as a scientific collaborator rather than just a tool. The partnership is well-received by the industry, aligning with the US Food and Drug Administration's push for advanced computer models in drug development. Lilly aims to lead the way in medical research, accelerating the delivery of new therapies to patients.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
